Compare EOLS & GPRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EOLS | GPRK |
|---|---|---|
| Founded | 2012 | 2002 |
| Country | United States | Colombia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 550.9M | 649.0M |
| IPO Year | 2018 | 2009 |
| Metric | EOLS | GPRK |
|---|---|---|
| Price | $9.06 | $11.20 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | ★ $15.50 | $8.50 |
| AVG Volume (30 Days) | ★ 1.1M | 426.7K |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.26% |
| EPS Growth | ★ 1.23 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $297,176,000.00 | N/A |
| Revenue This Year | $13.27 | $39.45 |
| Revenue Next Year | $17.62 | N/A |
| P/E Ratio | ★ N/A | $12.70 |
| Revenue Growth | ★ 11.61 | N/A |
| 52 Week Low | $3.86 | $5.75 |
| 52 Week High | $9.15 | $11.87 |
| Indicator | EOLS | GPRK |
|---|---|---|
| Relative Strength Index (RSI) | 71.54 | 73.61 |
| Support Level | $5.78 | $8.98 |
| Resistance Level | N/A | $11.77 |
| Average True Range (ATR) | 0.38 | 0.34 |
| MACD | 0.04 | 0.17 |
| Stochastic Oscillator | 96.50 | 95.69 |
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.
GeoPark Ltd is an independent energy company. Its diversified portfolio of assets consist of Llanos 34 Block in Colombia, CPO-5 Block, Llanos 86, Llanos 87, Llanos 104, Llanos 123, and Llanos 124 Blocks in the Llanos Basin. Its segments include Colombia, Argentina, Brazil and Ecuador, with the majority of the revenue derived from Colombia. It derives revenue from Sale of crude oil, Sale of purchased crude oil, and Sale of gas.